Good-bad news for GI in 2023 CMS fee schedule | 33 updates from 2022 | Satisfai buys assets of AI startup Docbot | AI blood test for liver cancer
Praveen Suthrum
Cofounder, NextServices | Author, The Shift, Scope Forward | GI Mastermind
Gastro Health, GI Alliance and more: 33 industry updates in 2022 (Becker's GI & Endoscopy)
Here are 33 moves from major gastroenterology groups that Becker's has reported on in 2022.
Medicare expanded coverage of colorectal cancer (CRC) testing through the 2023 physician payment rule while also finalizing certain mandated budget cuts.
Satisfai Health Purchases Assets of Docbot, Inc.?(TheNewswire)
Through this acquisition, Satisfai plans to accelerate its product roadmap, improve quality assurance, and bring automated documentation of endoscopic procedures.
The shift to digital is real. Old service lines in GI are --- yes, old. If you are looking to take an elevator to the future,?there's nothing like this out there.
GI Mastermind?is a year-long program for busy GI leaders to build a bridge to the future. An overlap of digital + business + leadership. Exclusive guest webinars to know what you can't elsewhere.
Click here?to reserve your spot. GI Mastermind 2023 starts Jan 11th, 2023. Few spots left.
Are payers pushing procedures to ASCs??(Becker's ASC Review)
Dr. Laren Tan (Chair of Loma Linda (Calif.) University Health's Department of Medicine) and Craig Sarine. (CEO, University Surgical Associates) discuss whether payers are pushing procedures to ASCs and other outpatient settings.
Physician Leaders More Valuable Than Ever Before?(HealthLeaders)
Physicians are trained in optimal patient care when combined with administrative skills, they become dynamic leaders, according to the American Association for Physician Leadership.
Earnings delivered despite slower market procedure volume and supply recovery; Growth driven by TAVR, Pacing, U.S. Core Spine, and International Diabetes.
Johns Hopkins’ Artificial Intelligence-Based Blood Test Detects Liver Cancer (Health IT Analytics)
The novel artificial intelligence-based blood testing technology successfully detected more than 80 percent of liver cancer cases in a new study.
A Virgo-cluster worth of data at your fingertips!?(GI StartUp Podcast)
Matthew Schwartz, founder, and CEO of Virgo speaks on endoscopy video capture, artificial intelligence, and his entrepreneurial journey in this interview with Bara Kurdi, MD.
领英推荐
Will Newer Screening Methods Dethrone Colonoscopy??(GI & Endoscopy News)
In 10 years, will colonoscopy still be the standard screening modality for CRC? Despite NordICC trial results, it probably will, but it will undoubtedly be accompanied by new noninvasive options.
Round up of Healio's top stories based on presentations from the American College of Gastroenterology (ACG) Annual Scientific Meeting.
The issue of "untitling" a doctor and failing to use their honorific is becoming increasingly common, according to a recent study published in JAMA Network Open.
Data Show Breath Testing Can Help Hone Rx for Functional GI Symptoms (GI & Endoscopy News)
Data shows breath testing can help differentiate between IBS subtypes and distinguish IBS from sucrose malabsorption.
Deep-Learning Assessment of Liver Fat Identifies Risk of Severe COVID-19 (Health IT Analytics)
A deep-learning tool has shown that patients with nonalcoholic fatty liver disease were one-and-a-half times more likely to develop severe COVID-19.
Better Risk Assessment Needed for Colonoscopy Patients Taking Antithrombotic Agents (GI & Endoscopy News)
Pausing antithrombotic agents for colonoscopy was associated with higher odds of thromboembolic events after colonoscopy.
Triastek Receives FDA IND Clearance for 3D Printed Medicine for the Treatment of Ulcerative Colitis?(PR Newswire)
With a unique 3D dosage form design, T21 can reach the targeted colon segment of the GI tract, thus permitting use of a lower drug dose than the reference listed drug.
Bloating Common but Often Ignored: Survey?(Medscape)
The findings suggest doctors should "proactively" ask about bloating, especially in adults at increased risk, including women and those with IBS or IBD, researchers say.
Vice President - Global Med Device Leader Building Companies and Careers at TMG
1 年Bringing the ?? with relevant updates in the #gastroenterology space. Thanks Praveen Suthrum and Scope Forward ??